Skip to main content
editorial
. 2013 Jan 27;4(1):1–2. doi: 10.18632/oncotarget.824

Figure 1. Expression of SHH in prostate cancer.

Figure 1

Above: PN1- mediated blockade of SHH downstream signaling slows cancer proliferation and neo-angiogenesis. The effect can be inhibited by MMP9. Below: whole mount prostate tissue shows that SHH staining (brown) occurs primarily in prostate tumour cells rather than normal prostate.